Compass Therapeutics, Inc.

CMPX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.3B · 39 employees
105
SEC Filings
$1.85
Close 2026-09-15
39
Employees

Business Summary

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics. Its pipeline includes four clinical-stage candidates: tovecimib (CTX-009), a DLL4/VEGF-A bispecific antibody in Phase 2/3 for biliary tract cancer; CTX-471, a CD137 agonistic antibody; CTX-8371, a PD-1/PD-L1 bispecific antibody in Phase 1; and CTX-10726, a PD-1/VEGF-A bispecific antibody in Phase 1 dose escalation. The company targets angiogenesis, immune activation, and tumor immunosuppression pathways.

Latest Stock Quote

CMPX 2026-09-15 $1.85 O:$1.98 H:$1.98 L:$1.85 Vol:2.4M VWAP:$1.8878
origin leaf: null

Next Earnings

expected 2026-12-22

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001171843-26-001337EDGAR81K words
2025-02-272024-12-310001171843-25-001106EDGAR82K words
2024-03-212023-12-310001171843-24-001516EDGAR84K words
2023-03-152022-12-310001171843-23-001691EDGAR—
2022-03-182021-12-310000950170-22-004156EDGAR—
2021-03-052020-12-310001564590-21-011110EDGAR—
2020-06-082020-03-310001213900-20-014390EDGAR—
2019-07-012019-03-310001213900-19-011850EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300001171843-26-005295EDGAR16K words
2025-11-052025-09-300001171843-25-007005EDGAR14K words
2025-08-112025-06-300001171843-25-005261EDGAR14K words
2025-05-082025-03-310001171843-25-002953EDGAR12K words
2024-11-122024-09-300001171843-24-006248EDGAR15K words
2024-08-122024-06-300001171843-24-004670EDGAR14K words
2024-05-132024-03-310001171843-24-002785EDGAR13K words
2023-11-092023-09-300001171843-23-006912EDGAR18K words
2023-08-032023-06-300001171843-23-004947EDGAR17K words
2023-05-042023-03-310001171843-23-002868EDGAR—
2022-11-092022-09-300001171843-22-007269EDGAR—
2022-08-012022-06-300001171843-22-005187EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-220001171843-26-006162EDGAR1K words
2026-08-060001171843-26-005292EDGAR2K words
2026-03-050001171843-26-001336EDGAR2K words
2026-01-060001171843-26-000083EDGAR1K words
2025-11-050001171843-25-007004EDGAR3K words
2025-08-130001193125-25-179958EDGAR1K words
2025-08-110001171843-25-005260EDGAR3K words
2025-06-120001171843-25-003868EDGAR1K words
2025-05-080001171843-25-002952EDGAR2K words
2025-04-010001171843-25-001900EDGAR1K words

105 total filings indexed. 75 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

biliary-tract-cancer colorectal-cancer non-small-cell-lung-cancer triple-negative-breast-cancer hodgkin-lymphoma melanoma small-cell-lung-cancer mesothelioma oncology-/-immuno-oncology recist-1.1 simon-two-stage-adaptive-design rank-preserving-structural-failure-time-(rpsft)-method stitchmabs-platform

Company Identity

CIK0001738021
TickerCMPX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.compasstherapeutics.com
Listed2020-11-13

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 7d8a96bd25787c2d436cc5464bf63671b020431336568b368de21435b7ae7153
parent: bb5810e79139b7c7ad00da560de2b8aa207eaa4847c77d9cd3ee6961186f0069
content hash: 5f2317d100543777bda66c2b2383f470ca4414f4c69a20c4e521fe4bbf1bf4dc
signed: 2026-09-28T19:00:47.802Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up CMPX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on CMPX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/CMPX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.